real-time news and commentary for investors
Thursday, Jul 18
Illumina (ILMN +1%) agrees to dismiss all claims against Complete Genomics, a wholly-owned...
Illumina (ILMN +1%) agrees to dismiss all claims against Complete Genomics, a wholly-owned subsidiary of BGI-Shenzhen, saying it's entered into a settlement agreement under which it will dismiss both lawsuits it had filed. Complete Genomics, in turn, will dismiss all counterclaims, with each party bearing its own litigation costs. No payment is being made by either party to the other, and no licenses are being granted by either party to the other.